Baird Medical Investment Holdings (BDMD) Assets Average (2024 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Assets Average came in at $73.3 million in Q4 2025, up 8.93% year-on-year from $67.3 million in Q4 2024, and down 5.33% on a QoQ basis from $77.5 million in Q2 2025.
Baird Medical Investment Holdings (BDMD) Assets Average (2024 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 2 years of Assets Average data on file, last reported at $73.3 million in Q4 2025.
- On a quarterly basis, Assets Average rose 8.93% year-over-year to $73.3 million in Q4 2025; TTM through Dec 2025 was $73.3 million, a 8.93% increase from a year earlier, with the FY2025 full-year figure at $73.8 million, up 9.65% from the prior year.
- Assets Average for Q4 2025 stood at $73.3 million, down from $77.5 million in the prior quarter.
- Over the last five years, Assets Average for BDMD reached as high as $77.5 million in Q2 2025 and fell as low as $67.3 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 6.49 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 37.02 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 10.57 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 31.64 Bn |
| 10 | Baird Medical Investment Holdings | 29.46 Mn | 29.07 Mn | - | 73.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 73.35 Mn |
| Jun 30, 2025 | 77.48 Mn |
| Dec 31, 2024 | 67.34 Mn |